(b)(4).Date sent to fda: 06/15/2021.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information was requested and the following was obtained: diagnosis for suspected atypical nevi the index case caused the wound disruption, patient is generally well and not on any medications.Suture was used subcutaneous/dermal.Horizontal closure suture closure second time was continuous non locking (vicryl, not pds).Surgeon's etiology: pds reaction.Patient's current status is well healed.A manufacturing record evaluation was performed for the finished device lot number qemajr / w9950t14, and no non-conformances related to the reported complaint condition were identified.Related events captured via 2210968-2021-04748 and 2210968-2021-04749.
|